US to fund new research into psychedelic drug ibogaine
Digest more
Be with people you trust, keep the next day free, and remember the trip will end. Advice from a little-known 1967 LSD manual still wins broad agreement from today’s psychedelic users, a new survey finds.
Opinion
As psychedelic drugs near FDA decisions, people with HIV remain absent from trials, commentary says
Psychedelic therapies are nearing FDA decisions, but people with HIV, many covered by Medicaid, have been left out of nearly all trials, commentary authors argue.
Regulators in Australia have updated psychedelic medicine guidelines, but disagreements persist about who can and can’t lead therapy sessions.
Austin, United States, May 18, 2026 (GLOBE NEWSWIRE) -- "According to SNS Insider, the Psychedelic Drugs Market was estimated at USD 4.13 billion in 2025 and is expected to reach USD 14.90 billion by 2035 and grow at a CAGR of 13.68% over 2026-2035.
Delix Therapeutics has raised $100 million in a series C round backed by the likes of Johnson & Johnson to advance a phase 2-ready non-hallucinatory psychedelic therapy for depression. | Delix Therapeutics has raised $100 million in a series C round backed by the likes of Johnson & Johnson to advance a phase 2-ready non-hallucinatory psychedelic therapy for depression.
In recent years, psychedelic drugs have attracted growing interest as potential treatments for conditions including depression, anxiety and addiction. Although these drugs are often considered one group, researchers from the University of Southern Denmark ...
Due to the association between psychedelic drugs and mystical experiences, some recent research has looked at how the spiritual beliefs and attitudes of psychedelic drug users compare to users of non-psychedelic drugs and to non-drug users. A study by Lerner and Lyvers (2006) compared people who used high doses of classic psychedelic drugs (e.g. LSD, mescaline and psilocybin) with people who ...